Press Releases
 
Global Orphan Drugs Market Estimated to Exhibit 12.1% CAGR through 2025

, 13 February 2018 -- Orphan Drugs Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

In a moderately consolidated global orphan drugs market, players are primarily focused on strategic acquisitions and are strategizing to gain maximum returns on investments made for R&D of orphan drugs and to leverage the incentives offered by governments for research on orphan drugs, according to recent market intelligence by Transparency Market Research. In this scenario, some of the companies to hold a commanding position in the global orphan drugs market are Novartis AG, Celgene Corporation, Pfizer Inc., Alexion Pharmaceuticals Inc., GlaxoSmithKline plc, and Johnson & Johnson.

The global orphan drugs market is projected to display a healthy 12.1% CAGR from 2017 to 2025, for the market to reach a valuation of US$318.5 bn by the end of 2025.

Oncology to Remain Dominant Disease Type Segment through 2025

Vis-à-vis revenue, in 2016, oncology stood as the dominant segment based on disease type, and is expected to hold on to its dominant position over the forecast period. The increasing genetic mutations and the increasing burden of rare cancers are attributed to the growth of this segment.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1254

In terms of product type, biologic products led the market in 2016 on the basis of revenue. The segment is expected to display a significant CAGR over the forecast period backed by factors such as high efficacy, fewer side effects, and difficulty to develop generic versions of these drugs. Hospital pharmacies led the global orphan drugs market in terms of revenue in 2016 amongst all distribution channel segments.

North America held the leading share of the orphan drugs market in 2016. Within North America, the U.S. is a leading domestic market contributing substantial revenue to this market.

Government Aid and Tax Credits for Development of Orphan Drugs Benefits Market

As per an analyst at TMR, the global orphan drugs market is anticipated to expand at a significant growth rate on account of a number of factors. Amongst all, high return on investments for the development of orphan drugs is a key one. The development of phase- III orphan drugs costs over 50% more than the cost of development of non-orphan drugs. The return on investments is estimated to be over 1.2 times greater for phase- III orphan drugs than non-orphan drugs.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1254

In developed countries, strong focus on research and development of orphan drugs, which receives government aid, tax credits, and fee waivers is contributing to the growth of this market. As per records of the Research Office Legislative Council Secretariat, there are more than 30 million individuals suffering from rare diseases in the U.S. As a result, 4,171 drugs have received orphan drug status in the U.S., which is attracting drug manufacturers to invest in this market.

Furthermore, increasing number of rare diseases that are related to genetic reasons leading to investments for drug development of these diseases is benefitting the orphan drugs market. As per statistics of Global Genes, a non-profit organization, more than 7,000 types of rare diseases have been identified globally. At present, more than 300 million people worldwide are estimated to be affected by rare diseases that calls for considerable production of orphan drugs.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1254

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: http://www.transparencymarketresearch.com

# # #


Submitted by Sandy Researcher, Transparency Market Research on Tuesday, 13 February 2018 at 6:18 PM
Category: Health Care & Medical
 
Related News

Immunoassay Instruments Market to Reach US$23.3 bn by 2020
Monday, 21 May 2018

Continuous Glucose Monitoring Market to Grow at a CAGR of 13.60% through 2019
Monday, 21 May 2018

Medical Fiber Optics Market CAGR Projected to Grow at 7.60% through 2019
Monday, 21 May 2018

Surgical Navigation Systems Market to Reach US$295.5 Mn by 2020
Monday, 21 May 2018

Cell Culture Protein Surface Coatings Market will Exhibit a Steady 13.60% CAGR through 2020
Monday, 21 May 2018

Related Events

2018 Off-Label Regulatory Compliance Congress
Monday, 21 May 2018

4th European Clinical Trials Inspection Readiness
Monday, 21 May 2018

Medicaid Managed Care Congress
Monday, 21 May 2018

Drug Delivery Design & Partnering - May 21-22, 2018 - San Francisco, CA
Monday, 21 May 2018

Product Recalls Forum
Monday, 21 May 2018

Latest News

The ‘Shen Yun’ show provokes controversy
Tuesday, 22 May 2018

Mostofi Yachts Unveils New Yacht
Tuesday, 22 May 2018

How to select the Best crypto exchange service?
Monday, 21 May 2018

What are the benefits of using iCoin?
Monday, 21 May 2018

Ready to Assemble Furniture Market Outlook: Ken Research
Monday, 21 May 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 22 May 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Argus Latin America LNG Summit
  • Argus North American Natural Gas Markets
  • Drug Delivery Design & Partnering - May 21-22, 2018 - San Francisco, CA
  • 4th European Clinical Trials Inspection Readiness
  • 2018 Off-Label Regulatory Compliance Congress

  • Latest Jobs
    Sorry, there are currently no entries posted here.